Abionic SA
🇨🇭Switzerland
- Country
- 🇨🇭Switzerland
- Ownership
- -
- Established
- 2010-01-01
- Employees
- -
- Market Cap
- -
- Website
- http://www.abionic.com
Clinical Trials
8
Active:0
Completed:6
Trial Phases
0 Phases
Drug Approvals
0
Drug Approvals
No drug approvals found
This company may not have drug approvals in our database
Clinical Trials
abioSCOPE PSP Reference Range Study; Extension of AB-PSP-003
Completed
- Conditions
- Sepsis
- First Posted Date
- 2023-05-09
- Last Posted Date
- 2023-08-14
- Lead Sponsor
- Abionic SA
- Target Recruit Count
- 61
- Registration Number
- NCT05849935
- Locations
- 🇺🇸
Sundance Clinical, Saint Louis, Missouri, United States
Analytical Validation of the abioSCOPE Device With the IVD CAPSULE PSP Test: Comparison of PSP Values Measured With Venous Whole Blood and Those Measured With Arterial Whole Blood.
Completed
- Conditions
- SepsisSepsis Bacterial
- First Posted Date
- 2022-11-25
- Last Posted Date
- 2022-11-25
- Lead Sponsor
- Abionic SA
- Target Recruit Count
- 46
- Registration Number
- NCT05627076
- Locations
- 🇫🇷
CHU Limoges, Réanimation Polyvalente, Limoges, France
Prospective Study to Validate the Diagnostic Performance of IVD CAPSULE COVID-19-NP Test for the Detection of SARS-CoV-2
Completed
- Conditions
- COVID-19 PandemicCOVID-19
- First Posted Date
- 2022-10-27
- Last Posted Date
- 2023-05-03
- Lead Sponsor
- Abionic SA
- Target Recruit Count
- 440
- Registration Number
- NCT05596032
- Locations
- 🇮🇹
A.O Mauriziano di Torino, Torino, Italy
abioSCOPE IgE Assay to Aid in the Diagnosis of Allergies
Withdrawn
- Conditions
- Allergy to House DustAllergyAllergy to CatsAllergy to Dog DanderAllergy CockroachAllergic Asthma
- First Posted Date
- 2020-06-23
- Last Posted Date
- 2020-10-05
- Lead Sponsor
- Abionic SA
- Registration Number
- NCT04442932
- Locations
- 🇺🇸
George Washington University, Washington DC, Washington, District of Columbia, United States
🇺🇸Johns Hopkins University, Baltimore, Baltimore, Maryland, United States
🇺🇸Johns Hopkins, Baltimore, Maryland, United States
Reference Range for abioSCOPE® Device With the PSP Assay in a Generally Healthy Adult Population
Completed
- Conditions
- HealthySepsisSeptic Shock
- First Posted Date
- 2020-06-01
- Last Posted Date
- 2022-03-02
- Lead Sponsor
- Abionic SA
- Target Recruit Count
- 150
- Registration Number
- NCT04409561
- Locations
- 🇺🇸
Mercy Health St. Vincent, Toledo, Ohio, United States
- Prev
- 1
- 2
- Next
News
Abionic's CAPSULE PSP Receives FDA Approval for Early Sepsis Detection
Abionic's CAPSULE PSP, an innovative test for early sepsis detection, has received 510(k) clearance from the U.S. Food and Drug Administration (FDA).